MedPath

instillation of medicated oil through uretharal opening in Benign Prostatic Hyperplasia

Phase 2
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2021/06/034489
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subject diagnosed as Benign Prostatic Hyperplasia by clinical and investigative methods will

be selected.

Patients having IPSS Score 7- 20 should be included.

In USG findings, patients having Prostate gland weight more than 40 gm and Residual Urine

Volume above 30 ml should be included.13

In uroflometry Qmax 3- 20 ml/s should be included.

Exclusion Criteria

Patients with IPSS (International Prostate Symptom Score) above 20 (severe)

Patients having other systemic pathology like Tuberculosis, Renal Failure, Uncontrolled

Diabetes Mellitus And Uncontrolled Hypertension Etc..

Patients having other urinarysystem pathology like severe Urinary tract

infections, Nephrolithiasis, Urethral Stricture, Prostatitis

Patients suffering from Prostatic malignancy

Patients having congenital deformity of urogenital tract

HIV and HBsAg positive patients

Patients having PSA value above normal (above 10 ng/ml )should be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath